FdaApplication
ANDA 220298
Identifiers
- fda_app_no: ANDA220298
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2026-03-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BENZONATATE | BENZONATATE | 100MG | CAPSULE;ORAL |
| BENZONATATE | BENZONATATE | 200MG | CAPSULE;ORAL |
2 products